Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Nephrology | Urology | Family Medicine
Disease Category: Urinary Tract Infections
Location: United States, FL
Urinary Tract Study for Females suffering from moderate to severe pain and burning upon urination
Phase three, randomized, double-blind, multi center, parallel-group placebo-controlled study in females with a UTI to evaluate the efficacy of Phenazopyridine Hydrochloride Tablets, UPS 200mg for the symptomatic relief of moderate to severe pain and burning upon urination. Patients will be randomized in a 1 to 1 ratio to receive either the study drug or a placebo every eight hours over a 24 hour period. The study is a 24 to 72 hour study from time of patient consent through the final contact.
Patient Inclusion Criteria:
Females 18 and over who have a diagnosis of UTI presenting with pain and burning upon urination. Positive UTI dipstick confirmation required for study entry.
Patient Exclusion Criteria:
Women pregnant or breast feeding are excluded. non UTI diagnosis per dipstick are excluded. Use of any anti-infectives or pain medications one day prior to study start is excluded.Chronic infections excluded as are any known history of genitourinary anomalies or surgery with in 6 months prior to study start.
Cheryl Ahlstrom, Clinical Liaison
South Florida Medical Research
2150 Biscayne Blvd, Suite 300,
Aventura, FL 33180
If you would like to learn more about participating in this study, please send an email message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these